Sanuwave Health Inc. (NASDAQ:SNWV – Get Free Report) shares traded down 1.5% during trading on Thursday . The stock traded as low as $25.77 and last traded at $26.41. 168,998 shares changed hands during trading, an increase of 162% from the average session volume of 64,607 shares. The stock had previously closed at $26.81.
Analyst Upgrades and Downgrades
SNWV has been the subject of a number of research analyst reports. Northland Securities assumed coverage on Sanuwave Health in a report on Wednesday, September 3rd. They issued an “outperform” rating and a $55.00 target price for the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Sanuwave Health in a report on Wednesday, October 8th. Roth Capital set a $53.00 target price on Sanuwave Health and gave the stock a “buy” rating in a research report on Tuesday, October 7th. Wall Street Zen downgraded shares of Sanuwave Health from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Finally, Northland Capmk raised shares of Sanuwave Health to a “strong-buy” rating in a report on Wednesday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, Sanuwave Health currently has an average rating of “Moderate Buy” and a consensus price target of $54.00.
Get Our Latest Stock Report on Sanuwave Health
Sanuwave Health Stock Down 1.5%
Sanuwave Health (NASDAQ:SNWV – Get Free Report) last released its quarterly earnings results on Thursday, November 6th. The company reported $0.46 earnings per share (EPS) for the quarter. The firm had revenue of $11.45 million for the quarter.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the business. Legal & General Group Plc bought a new position in shares of Sanuwave Health in the second quarter worth about $26,000. Strategic Investment Solutions Inc. IL purchased a new stake in Sanuwave Health in the 1st quarter worth approximately $47,000. BNP Paribas Financial Markets purchased a new position in Sanuwave Health during the second quarter valued at approximately $46,000. Farther Finance Advisors LLC bought a new position in shares of Sanuwave Health in the third quarter worth approximately $57,000. Finally, Police & Firemen s Retirement System of New Jersey bought a new position in shares of Sanuwave Health in the second quarter worth approximately $52,000. 42.53% of the stock is currently owned by institutional investors.
Sanuwave Health Company Profile
SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.
Further Reading
- Five stocks we like better than Sanuwave Health
- How to Start Investing in Real Estate
- CAVA Stock Looking for Direction After Earnings Miss
- What is a buyback in stocks? A comprehensive guide for investors
- 3 Small AI Stocks Ready to Explode (All Under $20)
- How to Short Nasdaq: An Easy-to-Follow Guide
- After 16% Fall, Analysts Eye a Big Recovery in Meta Platforms
Receive News & Ratings for Sanuwave Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanuwave Health and related companies with MarketBeat.com's FREE daily email newsletter.
